Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liposarcoma × selinexor × Clear all

Phase

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 10 Multiple Myeloma 9 Recurrence 8 Lymphoma, Large B-Cell, Diffuse 4 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Endometrial Neoplasms 2 Congenital Abnormalities 2 Colorectal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Solid Tumors 1 Sarcoma, Endometrial Stromal 1 Salivary Gland Neoplasms 1 Pancreatic Neoplasms 1 Neurofibrosarcoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1

Interventions

Doxorubicin 13 Ifosfamide 8 Trabectedin 7 Radiotherapy 7 pazopanib 3 Filgrastim 3 temsirolimus 2 ribociclib 2 pegfilgrastim 2 eribulin 2 cixutumumab 2 brigimadlin 2 belinostat 2 Sunitinib 2 Radiotherapy, Conformal 2 Imatinib Mesylate 2 Gemcitabine 2 Dexamethasone 2 Cyclophosphamide 2 soblidotin 1 sitravatinib 1 siremadlin 1 selinexor 1 sargramostim 1 saracatinib 1 romidepsin 1 ridaforolimus 1 regorafenib 1 perifosine 1 pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02606461 2023-01-23

SEAL

Karyopharm Therapeutics Inc

Phase 2/3 Completed

342 enrolled 36 charts

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡